title: Steroid-resistant remitting seronegative symmetrical synovitis with pitting oedema associated with gout treated with etanercept.
authors.affiliation: Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: Puja
authors.initials: P
authors.lastname: Mehta
authors.affiliation: Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Chong
authors.affiliation: Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: Maresa T
authors.initials: MT
authors.lastname: Carulli
authors.affiliation: Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK. d.haskard@imperial.ac.uk.
authors.forename: Dorian O
authors.initials: DO
authors.lastname: Haskard
mesh_terms: D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004487:Edema / Q000150:complications / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006073:Gout / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D019233:Retreatment; D013585:Synovitis / Q000150:complications / Q000188:drug therapy*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D011239:Prednisolone; D000068800:Etanercept